# CHEN YU

CHEN YU of PALO ALTO, CA appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. 15 filing roles across Form D (13), Form ADV (2).

## Filings (15)

| Filed | Source | Entity | Role | Location |
| --- | --- | --- | --- | --- |
| — | Form ADV | [VISION INVESTMENT MANAGEMENT (ASIA) LIMITED](https://search.stillhousedata.com/firm/137701) | CHIEF OPERATIONS OFFICER | HONG KONG SAR |
| — | Form ADV | [VISION INVESTMENT MANAGEMENT (BVI) LIMITED](https://search.stillhousedata.com/firm/137703) | CHIEF COMPLIANCE OFFICER | ROAD TOWN, TORTOLA |
| 2010-09-14 | Form D | [Sagent Holding Co.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1369786&type=&dateb=&owner=include&count=40) | Director | SCHAUMBURG, IL |
| 2009-04-13 | Form D | [Nora Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1461695&type=&dateb=&owner=include&count=40) | Director | PALO ALTO, CA |
| 2016-10-18 | Form D | [SentreHEART Inc](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1336396&type=&dateb=&owner=include&count=40) | Director | REDWOOD CITY, CA |
| 2015-06-23 | Form D | [Nexcida Therapeutics, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1645368&type=&dateb=&owner=include&count=40) | Director | MENLO PARK, CA |
| 2024-01-10 | Form D | [LB PHARMACEUTICALS INC](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1691082&type=&dateb=&owner=include&count=40) | Director | NEW YORK, NY |
| 2021-11-10 | Form D | [Arbor Biotechnologies, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1707499&type=&dateb=&owner=include&count=40) | Director | CAMBRIDGE, MA |
| 2019-10-30 | Form D | [Vivo Capital Fund IX, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1750117&type=&dateb=&owner=include&count=40) | Director | PALO ALTO, CA |
| 2019-09-27 | Form D | [Vivo Capital Fund IX E&F, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1789681&type=&dateb=&owner=include&count=40) | Executive Officer | PALO ALTO, CA |
| 2023-08-10 | Form D | [ADARx Pharmaceuticals, Inc.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1802369&type=&dateb=&owner=include&count=40) | Director | San Diego, CA |
| 2021-04-14 | Form D | [TCG Crossover Fund I, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1839940&type=&dateb=&owner=include&count=40) | Executive Officer | PALO ALTO, CA |
| 2023-04-06 | Form D | [TCG Crossover Fund II, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1969281&type=&dateb=&owner=include&count=40) | Executive Officer | PALO ALTO, CA |
| 2025-06-26 | Form D | [TCG Crossover Fund III, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2062644&type=&dateb=&owner=include&count=40) | Executive Officer | PALO ALTO, CA |
| 2026-07-29 | Form D | [TCGX Asia Life Sciences Fund I, L.P.](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2140843&type=&dateb=&owner=include&count=40) | Related Person | PALO ALTO, CA |


---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.